Market News (Page 2) - TendieTensor

Market News Page 2 of 158 • 3,931 articles

Tumor Transcriptomics Research Report 2025: An $8.71 Billion Market by 2030, Driven by Rising Global Cancer Prevalence and Advancements in Genomic Sequencing Technologies

GlobeNewswire Inc. • Researchandmarkets.Com

Tumor Transcriptomics Research Report 2025: An $8.71 Billion Market by 2030, Driven by Rising Global Cancer Prevalence and Advancements in Genomic Sequencing Technologies

12/01/2025 10:00 AM • Global tumor transcriptomics market projected to grow from $6.02 billion in 2024 to $8.71 billion by 2030, driven by rising cancer prevalence and genomic sequencing advancements, with spatial transcriptomics emerging as a key technological trend.

TER - Expecting 27% year-over-year growth driven by AI applications and strong memory performance
TMO - Highlighted as a key market player in a growing market with significant projected expansion

#tumor transcriptomics #cancer research #genomic sequencing #spatial transcriptomics #molecular biology

Micron’s $338 Target: The AI Memory Supercycle Is Just Starting

Investing.com • Jeffrey Neal Johnson

Micron’s $338 Target: The AI Memory Supercycle Is Just Starting

12/01/2025 09:45 AM • Morgan Stanley raised Micron's price target to $338, signaling strong confidence in the company's potential during the AI-driven memory supercycle, driven by high demand for High-Bandwidth Memory (HBM) in AI infrastructure.

BAC - Mentioned as lowering price target for D.R. Horton, indicating cautious market outlook
MU - Strong financial performance with 49% revenue increase, gross margin expansion from 22% to 41%, and strategic positioning in AI memory market with Data Center business now representing 56% of total revenue

#AI #semiconductor #memory chips #HBM #infrastructure

Why Is Small-Cap Q32 Bio Stock Soaring On Monday?

Benzinga • Vandana Singh

Why Is Small-Cap Q32 Bio Stock Soaring On Monday?

12/01/2025 09:43 AM • Q32 Bio sold its Phase 2 complement inhibitor ADX-097 to Akebia Therapeutics for $12 million in upfront payments, with potential milestone payments up to $592 million, causing its stock to surge by over 115%.

BACpB - Mentioned as lowering price target for D.R. Horton, indicating cautious market outlook
QTTB - Received significant upfront payment, retained rights to other assets, and stock price increased dramatically after the deal

#biotech #drug development #acquisition #complement inhibitor #milestone payments

Nvidia Just Delivered Amazing News to Investors for 2026

The Motley Fool • Adria Cimino

Nvidia Just Delivered Amazing News to Investors for 2026

12/01/2025 09:35 AM • Nvidia continues to dominate the AI chip market, with projected hyperscaler infrastructure spending reaching $600 billion in 2026, signaling strong potential growth and continued market leadership in artificial intelligence technology.

BACpE - Mentioned as lowering price target for D.R. Horton, indicating cautious market outlook
NVDA - Demonstrated explosive growth from $27B to $130B annual revenue, leading AI chip market, strong projected infrastructure spending, and 1,200% stock price gain over five years

#AI #chips #hyperscalers #infrastructure spending #GPU #technology

Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion

GlobeNewswire Inc. • Meng Li

Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion

12/01/2025 09:00 AM • Avalon GloboCare expanded its KetoAir™ breathalyzer device internationally to the UK, launched a first responder wellness program in Nevada, and showcased its metabolic health monitoring technology at a London summit.

FpC - Committed $5 billion to EV investments, indicating continued market growth potential
ALBT - Company demonstrated growth through international market entry, new health program launch, and technology showcase, indicating positive business momentum

#KetoAir #metabolic health #breathalyzer #wellness #international expansion

Arqit Quantum Inc. Sets Fiscal year 2025 Conference Call for Tuesday, December 9, 2025 at 11:00 a.m. ET

GlobeNewswire Inc. • Arqit Quantum Inc.

Arqit Quantum Inc. Sets Fiscal year 2025 Conference Call for Tuesday, December 9, 2025 at 11:00 a.m. ET

12/01/2025 09:00 AM • Arqit Quantum Inc. will report its fiscal year 2025 financial results on December 9, 2025, hosting a conference call with CEO Andy Leaver and CFO Nick Pointon to discuss the company's performance.

FpB - Committed $5 billion to EV investments, indicating continued market growth potential
ARQQ - The article is a standard financial conference call announcement without strong positive or negative indicators, presenting routine corporate communication about upcoming financial reporting

#quantum encryption #financial results #conference call #cybersecurity

NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors

GlobeNewswire Inc. • Neonc Technologies Holdings, Inc.

NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors

12/01/2025 09:00 AM • NeOnc Technologies revealed preclinical research demonstrating that ultrasound can enhance the therapeutic potency of NEO100 for treating primary and metastatic brain tumors, using an AI-driven 3D-bioprinted methodology.

F - Committed $5 billion to EV investments, indicating continued market growth potential
NTHI - The company presented promising research showing potential breakthrough in brain tumor treatment using AI and ultrasound technology, which could significantly expand their commercial and clinical opportunities

#AI #ultrasound #brain tumors #sonodynamic therapy #3D bioprinting

Dr. Fidelio Tata Joins Seda Experts in Germany as a Leading Expert in Financial Markets and the Investment Industry

GlobeNewswire Inc. • Dr. Fidelio Tata

Dr. Fidelio Tata Joins Seda Experts in Germany as a Leading Expert in Financial Markets and the Investment Industry

12/01/2025 09:00 AM • Dr. Fidelio Tata, an internationally recognized finance expert with nearly 30 years of experience, has joined SEDA Experts LLC as Managing Director, bringing extensive expertise from top Wall Street firms and current academic work in finance.

HSBC - Mentioned as a previous employer of Dr. Tata with no specific positive or negative context

#financial markets #expert witness #derivatives #investment industry #finance professor

Off The Hook Yachts Reminds Boat Buyers that the “One Big Beautiful Bill” Reinstated 100% Bonus Depreciation for Boats Bought By January 19, 2026

GlobeNewswire Inc. • Jason Ruegg

Off The Hook Yachts Reminds Boat Buyers that the “One Big Beautiful Bill” Reinstated 100% Bonus Depreciation for Boats Bought By January 19, 2026

12/01/2025 09:00 AM • Off The Hook Yachts is reminding U.S. boat buyers about the 'One Big Beautiful Bill Act' which reinstates 100% bonus depreciation for qualifying business boats through January 19, 2026, allowing eligible buyers to deduct the entire purchase price in the first year if used over 50% for business purposes.

REGN - Successful collaborative development of Dupixent, promising clinical trial results, potential expansion of drug's approved indications
OTH - Company is proactively informing customers about a beneficial tax opportunity that could boost their business and customer interest

#bonus depreciation #boat purchase #tax incentive #business assets

UnitedHealth Unwinds Last South America Asset In $1 Billion Banmedica Sale

Benzinga • Vandana Singh

UnitedHealth Unwinds Last South America Asset In $1 Billion Banmedica Sale

12/01/2025 08:46 AM • UnitedHealth Group has agreed to sell its remaining South American operation, Banmedica, to Brazilian private equity firm Patria Investments for $1 billion, continuing its strategy to streamline operations and exit Latin American markets.

FpD - Committed $5 billion to EV investments, indicating continued market growth potential
UNH - The company is strategically divesting its South American assets after experiencing significant financial losses, indicating a calculated restructuring effort to improve overall business performance

#divestment #healthcare #South America #private equity #asset sale

Leggett & Platt Shares Surge On Somnigroup Acquisition Proposal

Benzinga • Lekha Gupta

Leggett & Platt Shares Surge On Somnigroup Acquisition Proposal

12/01/2025 08:43 AM • Somnigroup International proposed an all-stock acquisition of Leggett & Platt at $12.00 per share, representing a 30.3% premium to its 30-day average closing price.

TSLA - Planning significant EV production and capital spending ramp-up in 2026
LEG - Stock price surged 10.58% on acquisition proposal with significant premium

#acquisition #merger #stock transaction #premium

Solid Biosciences Receives FDA Rare Pediatric Disease Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia

GlobeNewswire Inc. • Solid Biosciences Inc.

Solid Biosciences Receives FDA Rare Pediatric Disease Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia

12/01/2025 08:00 AM • Solid Biosciences received FDA Rare Pediatric Disease designation for SGT-212, a dual-route gene therapy targeting Friedreich's ataxia. The therapy aims to restore frataxin protein levels and address neurologic, cardiac, and systemic disease manifestations.

SLDB - Company received important FDA designations (Rare Pediatric Disease and Fast Track) for its investigational gene therapy, indicating promising progress in developing a treatment for a rare genetic disorder

#gene therapy #Friedreich's ataxia #FDA designation #rare disease

ProQR to Participate in 8th Annual Evercore Healthcare Conference

GlobeNewswire Inc. • Proqr Therapeutics N.V.

ProQR to Participate in 8th Annual Evercore Healthcare Conference

12/01/2025 08:00 AM • ProQR Therapeutics will participate in the 8th Annual Evercore Healthcare Conference, presenting its Axiomer™ RNA editing technology platform that enables targeted single nucleotide changes in RNA to potentially develop new disease treatments.

PRQR - Company is presenting innovative RNA editing technology, announcing conference participation, and highlighting potential for developing new medical treatments across diverse disease types

#RNA therapy #Axiomer #RNA editing #ADAR #biotechnology

Wood Mackenzie appoints new Chief Commercial Officer

GlobeNewswire Inc. • Wood Mackenzie

Wood Mackenzie appoints new Chief Commercial Officer

12/01/2025 08:00 AM • Wood Mackenzie has appointed Danny Dunn as Chief Commercial Officer, bringing over 25 years of experience in go-to-market strategy from Morningstar and IBM. CEO Jason Liu highlighted Dunn's expertise in scaling global SaaS and data businesses.

IBM - Referenced as previous workplace of Danny Dunn with no specific positive or negative context

#appointment #leadership #commercial strategy #data analytics

ARKO Corp. Appoints Galagher Jeff as Chief Financial Officer

GlobeNewswire Inc. • Arko Corp.

ARKO Corp. Appoints Galagher Jeff as Chief Financial Officer

12/01/2025 08:00 AM • ARKO Corp. announced the appointment of Galagher Jeff as Executive Vice President and Chief Financial Officer, effective December 1, 2025. Jeff brings extensive experience from leadership roles in finance and strategy across multiple retail and convenience store organizations.

ARKO - Company is strengthening leadership team with an experienced executive who has a strong background in finance and retail strategy

#CFO appointment #convenience store #leadership transition

Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy

GlobeNewswire Inc. • Royal Philips

Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy

12/01/2025 08:00 AM • Philips announced expanded commercial availability of LumiGuide, a groundbreaking AI-enabled 3D navigation system that uses light instead of X-ray for medical procedures, improving safety and efficiency in endovascular treatments across Europe and the United States.

REGN - Collaborative success in developing Dupixent with promising clinical trial outcomes and potential FDA approval
PHG - Introducing innovative medical technology that improves procedural safety, reduces radiation exposure, and enhances clinical precision

#AI #medical technology #navigation #radiation reduction #endovascular procedures

STMicroelectronics announces status of common share repurchase program

GlobeNewswire Inc. • Stmicroelectronics

STMicroelectronics announces status of common share repurchase program

12/01/2025 08:00 AM • STMicroelectronics repurchased 206,478 ordinary shares between November 21-25, 2025, representing 0.02% of its issued share capital, at a weighted average price of €19.1345 per share, totaling €3,950,859.05.

STM - The share repurchase is a routine financial activity indicating stable corporate management, with the purpose of meeting share option program obligations. The transaction does not suggest significant positive or negative market implications.

#share repurchase #treasury shares #stock buyback #semiconductor

Firefly Aerospace Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - FLY

GlobeNewswire Inc. • Djs Law Group

Firefly Aerospace Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - FLY

12/01/2025 07:50 AM • Firefly Aerospace Inc. faces a class action lawsuit alleging false and misleading statements about its Spacecraft Solutions division and Alpha rocket's commercial potential during its IPO period.

FLY - Accused of making false and misleading statements about company's spacecraft division and rocket's commercial potential, which could damage investor confidence and company reputation

#securities lawsuit #IPO #class action #misleading statements

Syndax Announces Participation at the 8th Annual Evercore Healthcare Conference

GlobeNewswire Inc. • Michael A. Metzger

Syndax Announces Participation at the 8th Annual Evercore Healthcare Conference

12/01/2025 07:00 AM • Syndax Pharmaceuticals' CEO will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference, discussing the company's innovative cancer therapies and pipeline developments.

CARR - Mentioned as a partnership with no specific context indicating sentiment
SNDX - Company is showcasing its innovative cancer therapies, highlighting FDA-approved drugs Revuforj and Niktimvo, and actively conducting clinical trials, indicating growth and strategic development

#cancer therapies #pharmaceutical conference #investor relations

AmpliTech 5G Division Releases New Band 50 Open RAN Radios

GlobeNewswire Inc. • Fawad Maqbool

AmpliTech 5G Division Releases New Band 50 Open RAN Radios

12/01/2025 07:00 AM • AmpliTech Group has released new Band 50 (n50) 5G Open RAN radios designed for large-scale Fixed Wireless Access network deployments, targeting rural and challenging geographical areas with high-efficiency, interoperable radio technology.

GEV - Mentioned as a joint venture partner with no specific context indicating sentiment
AMPG - Company announced successful field trials, received production approval, and expects revenue increase from $78M to over $100M with new radio technology deployment

#5G #Open RAN #Fixed Wireless Access #telecommunications #radio technology

Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference

GlobeNewswire Inc. • Brian Luque

Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference

12/01/2025 07:00 AM • Fractyl Health's CEO, Dr. Harith Rajagopalan, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on December 3, 2025, discussing the company's metabolic therapeutics approach to treating obesity and type 2 diabetes.

AIRJW - Standard financial reporting announcement with no explicit positive or negative indicators
GUTS - The company is showcasing its innovative approach to metabolic disease treatment, highlighting clinical momentum with Revita® procedure and expanding its patent portfolio, indicating growth and potential

#metabolic therapeutics #obesity #type 2 diabetes #conference #healthcare

Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD)

GlobeNewswire Inc. • Not Specified

Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD)

12/01/2025 07:00 AM • Regeneron and Tessera Therapeutics announced a global collaboration to develop TSRA-196, a potential one-time gene editing treatment for Alpha-1 Antitrypsin Deficiency, with Tessera receiving $150 million upfront and sharing development costs and future profits equally.

REGN - Expanding genetic medicine portfolio, partnering with innovative biotech company, demonstrating leadership in developing transformative treatments

#gene editing #genetic medicine #AATD #collaboration #therapeutic development

Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg (NX-5948) To Be Presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition

GlobeNewswire Inc. • Nurix Therapeutics

Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg (NX-5948) To Be Presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition

12/01/2025 07:00 AM • Nurix Therapeutics will host a webcast on December 8, 2025, to present new clinical data on bexobrutideg (NX-5948), an investigational BTK degrader for treating chronic lymphocytic leukemia and Waldenström macroglobulinemia.

META - Mentioned in market movers with price decline (-2.67%)
NRIX - Company is presenting promising clinical trial data, expanding research into targeted protein degradation medicines, and hosting an informative webcast about their drug development progress

#BTK degrader #bexobrutideg #clinical trial #leukemia #webcast

Benzinga • Globe Newswire

Brookfield to Acquire Fosber

12/01/2025 06:45 AM • Brookfield Asset Management has agreed to acquire Fosber, a global leader in corrugated packaging machinery, for approximately $900 million. The transaction involves carving out Fosber from Guangdong Dongfang Precision and is expected to close in 2026.

BAM - Expanding portfolio with strategic acquisition of a market-leading industrial technology business, demonstrating growth and investment expertise

#acquisition #private equity #packaging industry #industrial technology

Titan Mining Announces Strong Kilbourne Graphite Project Economics and Expanded U.S EXIM Support to Accelerate U.S. Graphite Independence

GlobeNewswire Inc. • Rita Adiani, Ceo And President Of Titan Mining

Titan Mining Announces Strong Kilbourne Graphite Project Economics and Expanded U.S EXIM Support to Accelerate U.S. Graphite Independence

12/01/2025 06:00 AM • Titan Mining revealed a promising Preliminary Economic Assessment for its Kilbourne Graphite Project, with potential to supply nearly 50% of U.S. natural graphite demand. The project demonstrates strong economics with a $513 million after-tax NPV and secured financial support from the Export-Import Bank of the United States.

TII - Strong project economics, government support, potential to supply significant domestic graphite demand, and strategic positioning in critical minerals sector

#graphite #critical minerals #mining #U.S. independence #economic assessment